ArticleBioinformatics (Oxford, England)2025
SimSon: simple contrastive learning of SMILES for molecular property prediction.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Computational approaches for drug-drug interaction prediction: a systematic review of data sources, modeling strategies, and evaluation frameworks.Frontiers in pharmacology · 2026Pooled it
- KAN-PROSPECT: a Kolmogorov-Arnold Networks-integrated framework for predicting the effects and adverse reactions of natural products via transfer learning.Scientific reports · 2026Article
- Generative pretraining for drug molecule design with bidirectional structure-property optimization.Communications chemistry · 2026Article
- A Systematic Survey and Benchmark of Deep Learning for Molecular Property Prediction in the Foundation Model Era.Journal of chemical theory and computation · 2026Review
- MMPCS: multi-view molecular pretraining based on consistency information and specific information.Bioinformatics (Oxford, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationMolecular property prediction with deep learning has accelerated drug discovery and retrosynthesis. However, the shortage of labeled molecular data and the challenge of generalizing across the vast chemical spaces pose significant hurdles for leveraging deep learning in molecular property prediction. This study proposes a self-supervised framework designed to acquire a Simplified Molecular Input Line Entry System (SMILES) representation, which we have dubbed Simple SMILES contrastive learning (SimSon). SimSon was pre-trained using unlabeled SMILES data through contrastive learning to grasp the SMILES representations.
resultsOur findings demonstrate that contrastive learning with randomized SMILES enriches the ability of the model to generalize and its robustness as it captures the global semantic context at the molecular level. In downstream tasks, SimSon performs competitively when compared to graph-based methods and even outperforms them on certain benchmark datasets. These results indicate that SimSon effectively captures structural information from SMILES, exhibiting remarkable generalization and robustness. The potential applications of SimSon extend to bioinformatics and cheminformatics, encompassing areas such as drug discovery and drug-drug interaction prediction. AVAILABILITY AND IMPLEMENTATION: The source code is available at https://github.com/lee00206/SimSon.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.